Medexus Pharmaceuticals Inc (MDP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,066 | 4,452 | 5,363 | 2,346 | 3,943 |
| Receivables | 479 | 263 | 237 | 366 | 437 |
| Inventories | 358 | 302 | 292 | 339 | 317 |
| TOTAL | $3,946 | $5,065 | $5,998 | $3,068 | $4,716 |
| Non-Current Assets | |||||
| PPE Net | 38 | 46 | 47 | 59 | 66 |
| Intangibles | 1,216 | 1,111 | 1,111 | 1,304 | 754 |
| Other Non-Current Assets | 0 | 0 | 0 | 6 | 0 |
| TOTAL | $1,254 | $1,157 | $1,158 | $1,368 | $819 |
| Total Assets | $5,200 | $6,222 | $7,156 | $4,436 | $5,536 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2 | 3 | 3 | 4 | N/A |
| Accounts payable and accrued liabilities | 618 | 700 | N/A | N/A | N/A |
| Accrued Expenses | 127 | 136 | N/A | N/A | N/A |
| TOTAL | $747 | $838 | $788 | $435 | $525 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,733 | 2,921 | 2,826 | 1 | 6 |
| Deferred Revenues | N/A | N/A | 0 | 2 | 4 |
| TOTAL | $2,733 | $2,921 | $2,826 | $1 | $6 |
| Total Liabilities | $3,480 | $3,760 | $3,614 | $436 | $531 |
| Shareholders' Equity | |||||
| Retained earnings | -16,394 | -16,962 | -15,350 | -15,146 | -14,748 |
| TOTAL | $1,720 | $2,463 | $3,542 | $4,000 | $5,004 |
| Total Liabilities And Equity | $5,200 | $6,222 | $7,156 | $4,436 | $5,536 |